PFE — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Pfizer Inc.
Healthcare · $27.4
2.4
/10
Weak Entry
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
How this score works → Try the calculator ↓
Regime
Bullish
vs SMA200
SMA200 Distance
+1.4%
Above trend
Volatility
Normal
Average premiums
Momentum
Decelerating
4th day
About Pfizer Inc.
Pfizer sells prescription drugs and vaccines — Eliquis, Paxlovid, and oncology treatments drive most revenue. Very low beta (~0.4), deep dividend yield near 6%, but payout ratio stretched above 100%. High option premiums for a pharma name; attractive for put sellers seeking income, though pipeline risk and debt load deserve attention.
Drug Manufacturers — General
Market Cap
$156.2B
P/E Ratio
39.1
Dividend
6.3%
Beta
0.30
52-Week Range Current: $27.4
$23.62 $31.44
Earnings
2027-02-02
73 days away

PFE — oversold readings while price holds 1.4% above the 200-day average have historically resolved as corrective pullbacks rather than regime changes, settling within a 2–3 week horizon that fits inside a typical CSP expiry.

Based on end-of-day market dataScored by ThetaLoop Research
PFE ranks #12 of 66 Healthcare tickers by put-selling score (612 total screened)

Position Size & Yield Calculator

Live model for PFE — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0 —
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
ABBV AbbVie Inc. 5.5 CLOV Clover Health Investments, Corp. 4.4 CRSP CRISPR Therapeutics AG 4.4 BIIB Biogen Inc. 3.9 INO Inovio Pharmaceuticals, Inc. 3.5 Browse all Healthcare tickers →
📌 Embed this score on your blog
The PFE X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/PFE" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/PFE">PFE X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Public Trade Ledger — All Recorded Closed Outcomes
Cash-Secured Put ledger ↗ · See a sample →